Compare BELFA & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BELFA | AXGN |
|---|---|---|
| Founded | 1949 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | N/A | N/A |
| Metric | BELFA | AXGN |
|---|---|---|
| Price | $154.11 | $29.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $33.67 |
| AVG Volume (30 Days) | 32.1K | ★ 992.8K |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | ★ 0.16% | N/A |
| EPS Growth | ★ 19.52 | N/A |
| EPS | ★ 5.17 | N/A |
| Revenue | ★ $649,376,000.00 | $214,709,000.00 |
| Revenue This Year | $28.52 | $21.57 |
| Revenue Next Year | $6.49 | $15.79 |
| P/E Ratio | $29.23 | ★ N/A |
| Revenue Growth | ★ 23.70 | 18.72 |
| 52 Week Low | $53.95 | $9.22 |
| 52 Week High | $158.32 | $34.24 |
| Indicator | BELFA | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 66.89 | 61.08 |
| Support Level | $146.40 | $28.88 |
| Resistance Level | $158.32 | $30.76 |
| Average True Range (ATR) | 4.51 | 1.48 |
| MACD | 2.14 | -0.25 |
| Stochastic Oscillator | 87.84 | 35.46 |
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.